Record Information |
---|
Version | 1.0 |
---|
Created at | 2021-06-21 00:33:10 UTC |
---|
Updated at | 2021-06-30 00:18:30 UTC |
---|
NP-MRD ID | NP0043040 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | tenuicausine |
---|
Provided By | JEOL Database![JEOL Logo](/attributions/jeol_logo.png) |
---|
Description | Mekongenine B belongs to the class of organic compounds known as eburnan-type alkaloids. These are alkaloids with a structure based on the eburnan skeleton, that arises from rearrangement of the aspidospermidine ring system, involving migration of C-21 from C-7 to C-2, fission of the 2,16-bond, and attachment of C-16 to N-1. tenuicausine is found in Melodinus suaveolens and Melodinus tenuicaudatus. It was first documented in 2021 (PMID: 34130356). Based on a literature review very few articles have been published on Mekongenine B (PMID: 34130335) (PMID: 34130218) (PMID: 34130164) (PMID: 34130154). |
---|
Structure | [H]N1C2=C([H])C(OC([H])([H])[H])=C(C([H])=C2[C@]23C1=C(C(=O)OC([H])([H])[H])C([H])([H])[C@@]1(C([H])=C([H])C([H])([H])N(C([H])([H])C2([H])[H])[C@]31[H])C([H])([H])C([H])([H])[H])[C@]1([H])N2C3=C(C([H])=C([H])C([H])=C3[H])C3=C2[C@@]2([H])N(C([H])([H])C([H])=C([H])[C@@]2(C([H])([H])C([H])([H])[H])C1([H])[H])C([H])([H])C3([H])[H] InChI=1S/C41H46N4O3/c1-5-39-14-9-17-43-19-13-26-25-11-7-8-12-31(25)45(34(26)36(39)43)32(24-39)27-21-29-30(22-33(27)47-3)42-35-28(37(46)48-4)23-40(6-2)15-10-18-44-20-16-41(29,35)38(40)44/h7-12,14-15,21-22,32,36,38,42H,5-6,13,16-20,23-24H2,1-4H3/t32-,36-,38+,39+,40+,41+/m1/s1 |
---|
Synonyms | Not Available |
---|
Chemical Formula | C41H46N4O3 |
---|
Average Mass | 642.8440 Da |
---|
Monoisotopic Mass | 642.35699 Da |
---|
IUPAC Name | methyl (1R,12R,19S)-12-ethyl-4-[(15R,17R,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2(7),3,5,8(18),13-pentaen-17-yl]-5-methoxy-8,16-diazapentacyclo[10.6.1.0^{1,9}.0^{2,7}.0^{16,19}]nonadeca-2,4,6,9,13-pentaene-10-carboxylate |
---|
Traditional Name | methyl (1R,12R,19S)-12-ethyl-4-[(15R,17R,19S)-15-ethyl-1,11-diazapentacyclo[9.6.2.0^{2,7}.0^{8,18}.0^{15,19}]nonadeca-2(7),3,5,8(18),13-pentaen-17-yl]-5-methoxy-8,16-diazapentacyclo[10.6.1.0^{1,9}.0^{2,7}.0^{16,19}]nonadeca-2,4,6,9,13-pentaene-10-carboxylate |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H]N1C2=C([H])C(OC([H])([H])[H])=C(C([H])=C2[C@]23C1=C(C(=O)OC([H])([H])[H])C([H])([H])[C@@]1(C([H])=C([H])C([H])([H])N(C([H])([H])C2([H])[H])[C@]31[H])C([H])([H])C([H])([H])[H])[C@]1([H])N2C3=C(C([H])=C([H])C([H])=C3[H])C3=C2[C@@]2([H])N(C([H])([H])C([H])=C([H])[C@@]2(C([H])([H])C([H])([H])[H])C1([H])[H])C([H])([H])C3([H])[H] |
---|
InChI Identifier | InChI=1S/C41H46N4O3/c1-5-39-14-9-17-43-19-13-26-25-11-7-8-12-31(25)45(34(26)36(39)43)32(24-39)27-21-29-30(22-33(27)47-3)42-35-28(37(46)48-4)23-40(6-2)15-10-18-44-20-16-41(29,35)38(40)44/h7-12,14-15,21-22,32,36,38,42H,5-6,13,16-20,23-24H2,1-4H3/t32-,36-,38+,39+,40+,41+/m1/s1 |
---|
InChI Key | ZQWXPMGCNIJOIB-NKFPNAPDSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 600 MHz, acetone-d6, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, acetone-d6, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, acetone-d6, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, acetone-d6, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, acetone-d6, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, acetone-d6, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 300 MHz, acetone-d6, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, acetone-d6, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, acetone-d6, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, acetone-d6, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, acetone-d6, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, acetone-d6, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, acetone-d6, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, acetone-d6, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, acetone-d6, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, acetone-d6, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, acetone-d6, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, acetone-d6, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, acetone-d6, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, acetone-d6, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Not Available | Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as eburnan-type alkaloids. These are alkaloids with a structure based on the eburnan skeleton, that arises from rearrangement of the aspidospermidine ring system, involving migration of C-21 from C-7 to C-2, fission of the 2,16-bond, and attachment of C-16 to N-1. |
---|
Kingdom | Organic compounds |
---|
Super Class | Alkaloids and derivatives |
---|
Class | Eburnan-type alkaloids |
---|
Sub Class | Not Available |
---|
Direct Parent | Eburnan-type alkaloids |
---|
Alternative Parents | |
---|
Substituents | - Eburna alkaloid
- Plumeran-type alkaloid
- Indolo[3,2-1de][1,5]naphthyridine
- Pyridoindole
- Beta-carboline
- Carbazole
- 3-alkylindole
- Naphthyridine
- Dihydroindole
- Indole
- Indole or derivatives
- Phenol ether
- Anisole
- Alkyl aryl ether
- Secondary aliphatic/aromatic amine
- Aralkylamine
- Benzenoid
- N-alkylpyrrolidine
- Heteroaromatic compound
- Vinylogous amide
- Alpha,beta-unsaturated carboxylic ester
- Enoate ester
- Methyl ester
- Pyrrole
- Pyrrolidine
- Tertiary amine
- Amino acid or derivatives
- Tertiary aliphatic amine
- Carboxylic acid ester
- Secondary amine
- Monocarboxylic acid or derivatives
- Organoheterocyclic compound
- Azacycle
- Ether
- Enamine
- Carboxylic acid derivative
- Organooxygen compound
- Organic nitrogen compound
- Carbonyl group
- Organic oxygen compound
- Amine
- Organic oxide
- Hydrocarbon derivative
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Oude Voshaar RC, Dimitriadis M, vandenBrink RHS, Aprahamian I, Borges MK, Marijnissen RM, Hoogendijk EO, Rhebergen D, Jeuring HW: A 6-year prospective clinical cohort study on the bidirectional association between frailty and depressive disorder. Int J Geriatr Psychiatry. 2021 Jun 15. doi: 10.1002/gps.5588. [PubMed:34130356 ]
- Li N, Yamamoto G, Fuji H, Kisseleva T: Interleukin-17 in Liver Disease Pathogenesis. Semin Liver Dis. 2021 Jun 15. doi: 10.1055/s-0041-1730926. [PubMed:34130335 ]
- Narita K, Suganuma K, Murata T, Kondo R, Satoh H, Watanabe K, Sasaki K, Inoue N, Yoshimura Y: Synthesis and evaluation of trypanocidal activity of derivatives of naturally occurring 2,5-diphenyloxazoles. Bioorg Med Chem. 2021 Jul 15;42:116253. doi: 10.1016/j.bmc.2021.116253. Epub 2021 Jun 12. [PubMed:34130218 ]
- Aparicio JD, Espindola D, Montesinos VN, Litter MI, Donati E, Benimeli CS, Polti MA: Evaluation of the sequential coupling of a bacterial treatment with a physicochemical process for the remediation of wastewater containing Cr and organic pollutants. J Hazard Mater. 2021 Jun 6;418:126307. doi: 10.1016/j.jhazmat.2021.126307. [PubMed:34130164 ]
- Pandolfi EC, Hunt TJ, Goldsmith S, Hurlbut K, Silber SJ, Clark AT: Generation of three human induced pluripotent stem cell sublines (UCLAi005-A, UCLAi005-B and UCLAi005-C) for reproductive science research. Stem Cell Res. 2021 Jul;54:102409. doi: 10.1016/j.scr.2021.102409. Epub 2021 Jun 8. [PubMed:34130154 ]
- Liu, Y. -P., et al. (2013). Liu, Y. -P., et al, J. Nat. Prod. 76, 2322 (2013). J. Nat. Prod..
|
---|